Riyadh to host global biotech summit in September 2026

Riyadh will host RGMBS 2026 from Sept. 14-16, bringing together biotech leaders, investors, policymakers and researchers from more than 70 countries. The summit is designed to advance Saudi Arabia’s national biotech strategy and its goal of adding $34.6 billion to non-oil GDP by 2040.

Why it matters: - RGMBS 2026 is meant to help build Saudi Arabia’s biotech ecosystem from research to manufacturing and commercialization. - The summit aligns with the Kingdom’s national biotechnology strategy, which targets a $34.6 billion contribution to non-oil GDP by 2040. - The event aims to connect science, capital, policy and industry in one place, which can speed partnerships and dealmaking.

What happened: - Riyadh Global Medical Biotechnology Summit 2026 will take place in Riyadh, Saudi Arabia, from Sept. 14-16, 2026. - The summit will bring together scientists, investors, policymakers and health innovators across six themes: artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development. - The summit is expected to host more than 15,000 visitors, more than 100 local and international speakers, 200 biotech and healthcare brands, and more than 80 exhibitor organizations from government and industry. - Delegations from more than 70 countries are expected to attend. - Organizers are targeting more than 65 agreements and MoUs during the three-day event.

The details: - The scientific program follows the full biomedical innovation pipeline, from population genomics and AI-driven drug discovery to domestic biomanufacturing, regulatory science, commercialization and investment. - The summit is held under the supervision of the Ministry of National Guard Health Affairs. - King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences are hosting the event. - The Ministry of Investment, Invest Saudi and the Saudi Data and AI Authority are serving as key strategic partners. - Registration is open for delegates, exhibitors and industry partners. - The full scientific program, speaker list and event information are available at rgmbs.org.

Between the lines: - The summit is being positioned as more than a conference. It is a showcase for Saudi Arabia’s push to build scientific infrastructure, research capacity and a domestic biotech base. - A focus on laboratories, research centers, clinical trial networks, biomanufacturing and digital platforms signals an effort to move discoveries toward commercial use inside the Kingdom. - The event also highlights international partnerships, including collaborations with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in drug discovery. - Those partnerships suggest Riyadh wants to use global expertise to accelerate local capability building. - The summit’s emphasis on talent development, education, industry and regulation points to a longer-term workforce and policy strategy, not just a one-off event.

What’s next: - The summit will convene in Riyadh over three days in September 2026. - Organizers will use the event to advance scientific sessions, panel discussions, workshops and agreement signings. - Participants will get a closer look at Saudi Arabia’s regulatory framework, manufacturing infrastructure and research capacity. - More information is being shared under the hashtag #RGMBS2026.

The bottom line: - RGMBS 2026 is Saudi Arabia’s latest bid to turn Riyadh into a regional and global hub for biotech innovation, investment and talent.